Last updated on February 2018

Efficacy Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)


Brief description of study

Multi-center, double-masked randomized, efficacy, safety and pharmacokinetic (PK) study.

Detailed Study Description

Primary: Describe the efficacy of 0.25% and 0.5% topical timolol maleate GFS as assessed through IH changes in color. Secondary: Describe the safety and PK of topical timolol maleate GFS for treatment of IH.

Clinical Study Identifier: NCT02913612

Contact Investigators or Research Sites near you

Start Over

Sarah Chamlin, MD

Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, IL United States
  Connect »

Anita Haggstrom, MD

Indiana University Health
Indianapolis, IN United States
  Connect »

Kate Puttgen, MD

Johns Hopkins Medical Center
Baltimore, MD United States
  Connect »

Marilyn Liang, MD

Boston Children's Hospital
Boston, MA United States
  Connect »

Megha Tollefson, MD

Mayo Clinic
Rochester, MN United States
  Connect »

Maria Garzon, MD

Columbia University Medical Center
New York, NY United States
  Connect »

Adrienne Hammill, MD

Cincinnati Children's Hospital Medical Center
Cincinnati, OH United States
  Connect »

Jenna Streicher, MD

Children's Hospital of Philadephia
Philadelphia, PA United States
  Connect »

Adelaide Hebert, MD

The University of Texas Medical School at Houston
Houston, TX United States
  Connect »

Beth Drolet, MD

Medical College of Wisconsin
Milwaukee, WI United States
  Connect »